TY - JOUR
T1 - Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis
T2 - A European experience
AU - Lencioni, R.
AU - Pinto, F.
AU - Armillotta, N.
AU - Bassi, A. M.
AU - Moretti, M.
AU - Di Giulio, M.
AU - Marchi, S.
AU - Uliana, M.
AU - Della Capanna, S.
AU - Lencioni, M.
AU - Bartolozzi, C.
PY - 1997/1/1
Y1 - 1997/1/1
N2 - The objective of our work was to evaluate the long-term results of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC) in patients with liver cirrhosis. A total of 184 cirrhotic patients with HCC underwent PEI as the only anticancer treatment over an 8-year period. Patients were followed after therapy by means of clinical examinations, laboratory tests, and US and CT studies performed at regular time intervals. Survival rates were determined according to the Kaplan-Meier method. The overall survival was 67 % at 3 years, 41 % at 5 years, and 19 % at 7 years. The 3-, 5-, and 7-year survival rates of patients with single HCC ≤ 3 cm (78,54, and 28 %, respectively) were significantly higher (p < 0.01) than those of patients with single HCC of 3.1-5 cm (61, 32, and 16, respectively) or multiple HCCs (51, 21, and 0 %, respectively). Survival of Child-Pugh A patients (79 % at 3 years, 53 % at 5 years, and 32 % at 7 years) was significantly longer (p < 0.01) than that of Child-Pugh B patients (50 % at 3 years, 28 % at 5 years, and 8 % at 7 years). A selected group of 70 patients with Child-Pugh A cirrhosis and single HCC ≤ 3 cm had a 7-year survival of 42 %. Long-term survival of cirrhotic patients with HCC treated with PEI is comparable to that reported in published series of matched patients submitted to surgical resection.
AB - The objective of our work was to evaluate the long-term results of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC) in patients with liver cirrhosis. A total of 184 cirrhotic patients with HCC underwent PEI as the only anticancer treatment over an 8-year period. Patients were followed after therapy by means of clinical examinations, laboratory tests, and US and CT studies performed at regular time intervals. Survival rates were determined according to the Kaplan-Meier method. The overall survival was 67 % at 3 years, 41 % at 5 years, and 19 % at 7 years. The 3-, 5-, and 7-year survival rates of patients with single HCC ≤ 3 cm (78,54, and 28 %, respectively) were significantly higher (p < 0.01) than those of patients with single HCC of 3.1-5 cm (61, 32, and 16, respectively) or multiple HCCs (51, 21, and 0 %, respectively). Survival of Child-Pugh A patients (79 % at 3 years, 53 % at 5 years, and 32 % at 7 years) was significantly longer (p < 0.01) than that of Child-Pugh B patients (50 % at 3 years, 28 % at 5 years, and 8 % at 7 years). A selected group of 70 patients with Child-Pugh A cirrhosis and single HCC ≤ 3 cm had a 7-year survival of 42 %. Long-term survival of cirrhotic patients with HCC treated with PEI is comparable to that reported in published series of matched patients submitted to surgical resection.
KW - Alcohol
KW - Interventional procedure
KW - Liver neoplasms
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=0030629507&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030629507&partnerID=8YFLogxK
U2 - 10.1007/s003300050194
DO - 10.1007/s003300050194
M3 - Article
C2 - 9204330
AN - SCOPUS:0030629507
VL - 7
SP - 514
EP - 519
JO - European Radiology
JF - European Radiology
SN - 0938-7994
IS - 4
ER -